New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin (original) (raw)
Structure-Based Development of Anticancer Drugs
Mario Bianchet
Structure, 2001
View PDFchevron_right
Structure-Based Design and Synthesis of Lipophilic 2,4-Diamino-6-Substituted Quinazolines and Their Evaluation as Inhibitors of Dihydrofolate Reductases and Potential Antitumor Agents
Sherry Queener
Journal of Medicinal Chemistry, 1998
View PDFchevron_right
Structure based drug design of Pim-1 kinase followed by pharmacophore guided synthesis of quinolone-based inhibitors
Yusuf Al-hiari
Bioorganic & Medicinal Chemistry, 2017
View PDFchevron_right
Structural prediction of novel pyrazolo-pyrimidine derivatives against PIM-1 kinase: In-silico drug design studies
Vivek Asati
Journal of Molecular Structure, 2020
View PDFchevron_right
Structure-based design of thienobenzoxepin inhibitors of PI3-kinase
Vickie Tsui
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Discovery of novel anticancer candidates based on a combination strategy of synthesis, characterization, biological activity evaluation, consensus docking and molecular modeling
hend hekal
Journal of the Iranian Chemical Society
View PDFchevron_right
Identification of 4, 5-Dihydro-1 H-pyrazolo [4, 3-h] quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors
Paolo Cappella
Journal of medicinal …, 2010
View PDFchevron_right
Structure-based drug design and AutoDock study of potential protein tyrosine kinase inhibitors
hamed ali
Bioinformation, 2011
View PDFchevron_right
Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e] [1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity
Ibrahim F . Nassar
View PDFchevron_right
Antitumor Activity of Pyridocarbazole and Benzopyridoindole Derivatives that Inhibit Protein Kinase CK2
Freja Schmidt
2010
View PDFchevron_right
Interfacing chemical biology and drug discovery: report from the 50th International Conference on Medicinal Chemistry of the SCT (French Medicinal Chemistry Society), July 2-4, 2014, Rouen, France
Luc Van Hijfte
ACS chemical biology, 2014
View PDFchevron_right
Anti-Cancer Agents in Medicinal Chemistry
Chinweike Eze
Bentham sciences, 2022
View PDFchevron_right
Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives
Ahmed Khodair
Carbohydrate Research, 2019
View PDFchevron_right
Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine-(thio)urea hybrids as potential kinase inhibitors
İlkay Küçükgüzel
View PDFchevron_right
Computational analysis of benzofuran-2-carboxlic acids as potent Pim-1 kinase inhibitors
Abdul Wadood
Pharmaceutical Biology, 2014
View PDFchevron_right
Bioorganic Chemistry 79 (2018) 46–59 -5.pdf
Rajeshwar Reddy
View PDFchevron_right
Discovery of pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as novel CDK2 inhibitors: synthesis, biological and molecular modeling investigations†
Ibrahim F . Nassar
2022
View PDFchevron_right
QSAR and Anticancer Drug Design on Benzothienopyrimidinones as Promising Pim Kinase Inhibitors Utilizing Structural Descriptors
sarfaraz ahmed
International Journal of Quantitative Structure-Property Relationships, 2019
View PDFchevron_right
Molecular Modeling, Synthesis and Biological Evaluation of N-Phenyl-4-Hydroxy-6-Methyl-2-Quinolone-3-CarboxAmides as Anticancer Agents
Dima Sabbah
Molecules
View PDFchevron_right
Design, One Pot Synthesis and Molecular Docking Studies of Substituted-1H-Pyrido[2,1-b] Quinazolines as Apoptosis-Inducing Anticancer Agents
Raju Bathula
Asian Pacific Journal of Cancer Prevention, 2020
View PDFchevron_right
Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)
Jeffrey Madwed
Journal of Medicinal Chemistry, 2003
View PDFchevron_right
Design, synthesis and structure–activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents
Korany Ali
European Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies
Ghada Hassan
View PDFchevron_right
Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents
Iqbal Azad
Journal of Molecular Graphics & Modelling, 2018
View PDFchevron_right
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)
Zhenxiong Wang
Journal of Medicinal Chemistry, 2020
View PDFchevron_right
Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3- d ]pyrimidine-6-carbonitrile ( 7x ) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)
Venkat Pallela
Journal of Medicinal Chemistry, 2014
View PDFchevron_right
Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2
Adali Pecci
European Journal of Medicinal Chemistry, 2013
View PDFchevron_right
3D-QSAR and Docking Studies of a Series of β-Carboline Derivatives as Antitumor Agents of PLK1
Jahan B Ghasemi
Journal of Chemistry, 2014
View PDFchevron_right
Structure-based design of low-nanomolar PIM kinase inhibitors
Istvan Enyedy
Bioorganic & Medicinal Chemistry Letters, 2015
View PDFchevron_right
Non-ATP-Mimetic Organometallic Protein Kinase Inhibitor
Katja Kräling, Kathrin Wähler
ChemistryOpen, 2013
View PDFchevron_right
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors
Ryan Wurz
ACS Medicinal Chemistry Letters, 2016
View PDFchevron_right
Synthesis, characterization, molecular docking and in vitro anticancer activity of 3-(4-methoxyphenyl)-5-substituted phenyl-2-pyrazoline-1- carbothioamide
Avik Maji
International Journal of Research in Pharmaceutical Sciences, 2021
View PDFchevron_right